In Science this week: meiotic DNA double-strand break resection, and more.
Peter Nowell, one of the discoverers of the Philadelphia chromosome, has died.
Vice President Joe Biden plans to stay focused on cancer issues after leaving the White House, according to the Washington Post.
Max Planck Institute for Evolutionary Anthropology researchers are searching for ancient human DNA in the dirt of cave floors, NPR reports.
In Nature this week: molecular study of esophageal cancer, and more.
Researchers identify genes whose expression is dysregulated in premenstrual dysphoric disorder.
A new analysis looks at the fate of papers rejected by the journal Clinical Otolaryngology.
Social entrepreneurship is becoming more popular with scientists, Wired UK reports.
In Genome Research this week: study of minimized Bacillus subtilis genomes, new computational methods for population genome data, and more.
Using census data, a team of researchers has pulled together a picture of the US biomedical workforce.
Harvard professor tells NPR that the 21st Century Cures Act could lead patients to get treatments that won't work for them.
Human geneticist David Latchman faces a new research misconduct probe, the Guardian reports.
In PNAS this week: population genomic study of hematopoietic regulation, proteasome subunit patterns in cancer, and more.
The biggest biology stories of the year include the Zika virus, CRISPR, and more, according to Wired.
Researchers uncover anti-CRISPR proteins that could help genetic engineering to be safer.
Researchers try to increase numbers of minorities in cancer immunotherapy trials, the New York Times reports.
Some research labs are turning to group messaging apps to communicate, according to Nature News.
Two high school students in Kentucky uncovered novel bacteriophages as part of a genomics class, the Kentucky New Era reports.
The Atlantic writes that white nationalists are interested in genetic ancestry testing.
In Nature this week: European ash tree genome sequencing, and more.
The Wall Street Journal says President-elect Donald Trump's pick to lead the Department of Health and Human Services traded medical company stock while supporting legislation affecting such firms.
Critics point out conflicts among members of the National Academies of Sciences, Engineering, and Medicine's biotechnology panel, according to the New York Times.
A writer argues that gene editing might eliminate variants that are beneficial in some circumstances, the Telegraph reports.
In Genome Biology this week: 4C-seq to examine chromatin patterns in IBD, Iberian lynx demographic patterns, and more.
Genomic analysis of Shigella outbreak strains indicates increased virulence and antibiotic resistance.
Bitesize Bio's Gail Seigel offers some tips on running a low-budget lab.
The GRE isn't a good predictor of graduate school performance or productivity, according to two PLOS One studies.
Bitesize Bio has some advice for scientists ready to leave their current lab behind.
A trio of editors from the Nature family of journals describes what make a peer review a good one.